Reminder - Western Asset Variable Rate Strategic Fund (GFY) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 10/16/13, Western Asset Variable Rate Strategic Fund (GFY) will trade ex-dividend, for its monthly dividend of $0.0725, payable on 10/25/13. As a percentage of GFY's recent stock price of $16.88, this dividend works out to approximately 0.43%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for GFY, showing historical dividends prior to the most recent $0.0725 declared by Western Asset Variable Rate Strategic Fund:

GFY+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from GFY is likely to continue, and whether the current estimated yield of 5.15% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of GFY shares, versus its 200 day moving average:

Western Asset Variable Rate Strategic Fund 200 Day Moving Average Chart

Looking at the chart above, GFY's low point in its 52 week range is $16.54 per share, with $19.71 as the 52 week high point — that compares with a last trade of $16.88.
Earn a FREE $100 Membership to ValueForum, Just By Telling Us About Your Favorite Stock! (Offer ends 11/10/2013)

In Monday trading, Western Asset Variable Rate Strategic Fund shares are currently off about 0.2% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says